FN2 Earnings Intelligence
Amcor plc earnings overview
Latest Amcor plc (AMCR) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.
Amcor plc
The current analysis supports a constructive but conditional view: synergy capture and integration benefits are supporting earnings, while working-capital recovery, leverage reduction, volume growth and cost pass-through remain important evidence to monitor.
Amcor plc
Amcor's FY2026 Q3 results illustrate a company in active transformation following the Berry acquisition. Adjusted EPS of $0.96 beat consensus by a narrow margin while revenue of $5.91B exceeded estimates by 3.5%. The core story is execution: $77M in synergies were captured in Q3 alone, keeping the company on track for $270M in FY2026 synergies and $650M over three years. Six non-core divestiture agreements totaling roughly $500M in cash proceeds are underway to accelerate deleveraging. However, management lowered free cash flow guidance to $1.5-1.6B from prior levels due to a deliberate inventory build, which ties up working capital even as it buffers against geopolitical and supply-chain risk. Adjusted EPS guidance was maintained at $3.98-4.03. The market reacted positively on the session with a 5.4% abnormal move, but subsequent drift of -6.4% suggests investors are weighing the FCF…
Amcor plc
The quarter supports a constructive operating thesis built on acquisition synergies, portfolio optimization and resilient focus-category demand, but the evidence is not uniform: volume declines in Europe and the non-core North American beverage business remain important counterweights.
Amcor plc
The current analysis supports a measured view: Berry-related synergies and portfolio mix improvement provide an earnings-growth path, but weak North American demand and execution risk temper the outlook.
Amcor plc
Amcor's latest analysis is cautiously constructive: volume growth, cash generation and the Berry merger support the outlook, but execution and demand risks remain.
Amcor plc
The supplied analysis supports a cautiously constructive view: improving volumes, commercial execution and sustainable-packaging initiatives provide evidence for continued progress, but healthcare destocking, consumer demand and leverage leave the growth case dependent on execution.
Amcor plc
The supplied analysis supports a cautiously constructive operating thesis: volume recovery, productivity and higher-value growth initiatives provide support, but the evidence is not one-sided because destocking, inflation, restructuring and capital-allocation timing remain material constraints.
Amcor plc
Amcor's raised guidance, improving volumes and cost savings support a more constructive near-term operating picture, but the recovery remains uneven because healthcare and North American beverage are still weak.
Get the AMCR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.